Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 10/20 | 0.65 |
| ▸ | MAPT | P10636 | 8/20 | 0.65 |
| ▸ | GAA | P10253 | 7/20 | 0.65 |
| ▸ | MEN1 | O00255 | 4/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.65 |
| ▸ | SNCA | P37840 | 3/20 | 0.65 |
| ▸ | BCHE | P06276 | 2/20 | 0.65 |
| ▸ | ACHE | P22303 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.65 |
| ▸ | MAOA | P21397 | 1/20 | 0.65 |
| ▸ | CNR1 | P21554 | 1/20 | 0.65 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.65 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.65 |
| ▸ | HTR2C | P28335 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenothiazine SCHEMBL29349533 | 0.79 | NOX1 (1.00) | NOX1MAPTGAAMEN1KMT2A | |
| Phenothiazine SCHEMBL9114 | 0.79 | NOX1 (1.00) | NOX1MAPTGAAMEN1KMT2A | |
| Phenothiazine SCHEMBL6315328 | 0.79 | NOX1 (1.00) | NOX1MAPTGAAMEN1KMT2A | |
| Phenothiazine SCHEMBL2504207 | 0.79 | NOX1 (1.00) | NOX1MAPTGAAMEN1KMT2A | |
| Phenothiazine SCHEMBL29352248 | 0.79 | NOX1 (1.00) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL13873061 | 0.79 | NOX1 (0.63) | NOX1MAPTGAAMEN1KMT2A | |
| Phenothiazine SCHEMBL23683396 | 0.77 | NOX1 (0.94) | NOX1MAPTGAAMEN1KMT2A | |
| Phenothiazine SCHEMBL22467844 | 0.77 | NOX1 (0.94) | NOX1MAPTGAAMEN1KMT2A | |
| Phenothiazine SCHEMBL22467847 | 0.77 | NOX1 (0.94) | NOX1MAPTGAAMEN1KMT2A | |
| Phenothiazine SCHEMBL17028421 | 0.77 | NOX1 (0.94) | NOX1MAPTGAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111116510-A | 2-substituted methylene dihydrobenzo [ d ] thiazole derivatives and synthesis method and application thereof | 华东师范大学 | 2020-05-08 | — | — | CN | claimed |
| EP-0379200-A2 | Photopolymerizable composition | MITSUBISHI KASEI CORPORATION (JP) | 1990-07-25 | — | — | EP | claimed |
| US-4785097-A | Method for synthesizing spiro-oxazines | PPG INDUSTRIES, INC. (US) | 1988-11-15 | — | — | US | claimed |
| JP-62195076-A | — | — | None | — | — | JP | disclosed |
| US-11708358-B2 | Fungicidal oxadiazoles | FMC CORPORATION (US) | 2023-07-25 | — | — | US | disclosed |
| US-11697695-B2 | Polymerizable composition and optically anisotropic body using same | DIC CORPORATION (JP) | 2023-07-11 | — | — | US | disclosed |
| US-11697695-B2 | Polymerizable composition and optically anisotropic body using same | DIC CORPORATION (JP) | 2023-07-11 | — | — | US | disclosed |
| US-11186669-B2 | Polymerizable composition and optically anisotropic body using same | DIC CORPORATION (JP) | 2021-11-30 | — | — | US | disclosed |
| US-20210284766-A1 | RETARDATION FILM, ELLIPTICALLY POLARIZING PLATE, AND DISPLAY DEVICE INCLUDING THE SAME | DIC CORPORATION (JP) | 2021-09-16 | — | — | US | disclosed |
| US-10927263-B2 | Polymerizable composition and optically anisotropic body produced using the same | DIC CORPORATION (JP) | 2021-02-23 | — | — | US | disclosed |
| US-10723952-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2020-07-28 | — | — | US | disclosed |
| US-20070032493-A1 | Method for treating B cell regulated autoimmune disorders | SYNTA PHARMACEUTICALS CORP. (US) | 2007-02-08 | — | — | US | disclosed |
| US-6936725-B2 | Photochromic compounds | RODENSTOCK GMBH (DE) | 2005-08-30 | — | — | US | disclosed |
| CN-1139998-C | Electrically erasable molecular base organic electric bistable film device and its producing technology | 复旦大学 | 2004-02-25 | — | — | CN | disclosed |
| US-20030045714-A1 | Photochromic compounds | RODENSTOCK GMBH (DE) | 2003-03-06 | — | — | US | disclosed |
| CN-1352470-A | Electrically erasable molecular base organic electric bistable film device and its producing technology | UNIV FUDAN (CN) | 2002-06-05 | — | — | CN | disclosed |
| EP-0379200-A2 | Photopolymerizable composition | MITSUBISHI KASEI CORPORATION (JP) | 1990-07-25 | — | — | EP | disclosed |
| JP-S62195076-A | NOVEL SPIRONAPHTHOPYRAN COMPOUND | TORAY IND INC | 1987-08-27 | — | — | JP | disclosed |
| US-3943142-A | Dye intermediates and their preparation and use in the synthesis of methine dyes | EASTMAN KODAK COMPANY (US) | 1976-03-09 | — | — | US | disclosed |
| US-3943142-A | Dye intermediates and their preparation and use in the synthesis of methine dyes | EASTMAN KODAK COMPANY (US) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030045714-A1 | Photochromic compounds | PPOX, NOP58, ROR1 | NOX1 513/4885MAPT 1159/4885GAA 2883/4885 |
| US-10927263-B2 | Polymerizable composition and optically anisotropic body produced using the same | CRYAA, IK, LCP1 | NOX1 4765/4885MAPT 161/4885GAA 2071/4885 |
| US-11708358-B2 | Fungicidal oxadiazoles | OXA1L, NOX1, TH | NOX1 2/4885MAPT 224/4885GAA 516/4885 |
| US-10723952-B2 | Polymerizable compound and optically anisotropic body | SMC4, SMCHD1, PHOSPHO1 | NOX1 4755/4885MAPT 17/4885GAA 2816/4885 |
| US-20070032493-A1 | Method for treating B cell regulated autoimmune disorders | REL, NFATC1, BCL6 | NOX1 628/4885MAPT 4316/4885GAA 3596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.